ArticleChemistry & biodiversity2026
Fungicidal Activity and In Silico Studies of Triazoles Derived From Glycerol Against Neocosmospora falciformis, A Causal Agent of Guava Tree Decline.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Guava tree decline is a complex disease characterized by root rot caused by the soilborne fungus Neocosmospora falciformis. Current management strategies have proven unsatisfactory under field conditions, highlighting the need for research into alternative control methods. This study evaluated the fungicidal activity of seventeen glycerol-derived triazoles against the mycelial growth and sporulation of N. falciformis at concentrations of 1, 10, 100, 500, and 1000 µg/mL. The commercial fungicide tebuconazole was included as a positive control. At 1000 µg/mL, triazole 4l completely inhibited mycelial growth and eliminated N. falciformis spores. Triazoles 4i-4l and 4n-4q also showed satisfactory activity at the highest concentrations in both parameters evaluated. Molecular docking studies investigated the interactions of 1,2,3-triazole derivatives with a modeled lanosterol 14α-demethylase (FsCYP51) from N. falciformis. All derivatives exhibited favorable binding to the enzyme's active site, with binding energies comparable to those of the natural substrate lanosterol and slightly less favorable than that of tebuconazole. These findings suggest that the triazole derivatives effectively prevent lanosterol from accessing the catalytic pocket of FsCYP51, thereby inhibiting its conversion into ergosterol. Notably, the 4l derivative exhibited enhanced activity, likely due to its docked pose superimposed on tebuconazole, underscoring this compound as a candidate for fungicide development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.